RESEARCHERS from the
University of Cambridge believe
common cancer drug Bexarotene
may prevent the onset of
Alzheimer’s disease.
According to their findings
published in Science, Bexarotene
could be the first “neurostatin”, a
drug that works like a statin, but for
the brain rather than the heart.
Their premise is that in order for
the drug to be to effective it would
need to be given to people in their
30s to stop the dementia ever
developing.
Tests showed the medication
successfully delayed the onset of
Alzheimers both in a test tube and
in nematode worms.
The drug has been tested on
Alzheimer’s patients, and did not
reverse the condition, but scientists
now think that was because it was
given too late to be effective.The above article was sent to subscribers in Pharmacy Daily's issue from 16 Feb 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Feb 16
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.